These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inhaled lidocaine for the treatment of asthma: lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies. Abuan T; Yeager M; Montgomery AB J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):381-8. PubMed ID: 20958143 [TBL] [Abstract][Full Text] [Related]
25. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results. Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237 [TBL] [Abstract][Full Text] [Related]
26. Inhaled corticosteroids and asthma control in children: assessing impairment and risk. Rachelefsky G Pediatrics; 2009 Jan; 123(1):353-66. PubMed ID: 19117903 [TBL] [Abstract][Full Text] [Related]
27. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
28. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033 [TBL] [Abstract][Full Text] [Related]
29. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819 [TBL] [Abstract][Full Text] [Related]
30. Assessment of asthma control: the SERENA study. Corrado A; Renda T; Polese G; Rossi A; Respir Med; 2013 Nov; 107(11):1659-66. PubMed ID: 24045118 [TBL] [Abstract][Full Text] [Related]
31. Children with uncontrolled asthma and significant reversibility might show hypoxaemia. Taytard J; Lacin F; Nguyen TLT; Boizeau P; Alberti C; Beydon N Eur J Pediatr; 2020 Jun; 179(6):999-1005. PubMed ID: 32020332 [TBL] [Abstract][Full Text] [Related]
32. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma. Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397 [TBL] [Abstract][Full Text] [Related]
33. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K; Noonan M; Silkoff PE; Uryniak T Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [TBL] [Abstract][Full Text] [Related]
34. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma. Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315 [TBL] [Abstract][Full Text] [Related]
35. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385 [TBL] [Abstract][Full Text] [Related]
36. Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma. Pelaia G; Gallelli L; Romeo P; Renda T; Busceti MT; Proietto A; Grembiale RD; Marsico SA; Maselli R; Vatrella A Int J Clin Pharmacol Ther; 2011 Dec; 49(12):713-21. PubMed ID: 22122813 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960 [TBL] [Abstract][Full Text] [Related]
38. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM; Greenstone IR; Ducharme FM Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751 [TBL] [Abstract][Full Text] [Related]
39. Severe asthma exacerbations in the United States:: Incidence, characteristics, predictors, and effects of biologic treatments. Trevor J; Lugogo N; Carr W; Moore WC; Soong W; Panettieri RA; Desai P; Trudo F; Ambrose CS Ann Allergy Asthma Immunol; 2021 Nov; 127(5):579-587.e1. PubMed ID: 34273485 [TBL] [Abstract][Full Text] [Related]
40. Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations. Deschildre A; Béghin L; Salleron J; Iliescu C; Thumerelle C; Santos C; Hoorelbeke A; Scalbert M; Pouessel G; Gnansounou M; Edmé JL; Matran R Eur Respir J; 2012 Feb; 39(2):290-6. PubMed ID: 21852334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]